Literature DB >> 28808880

Increased miR-338-3p expression correlates with invasiveness of GH-producing pituitary adenomas.

Yang Jong Lee1, Jin Mo Cho2, Ju Hyung Moon3, Cheol Ryong Ku4, Jean Kim1, Sun Ho Kim5, Eun Jig Lee6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28808880     DOI： 10.1007/s12020-017-1390-6

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  19 in total

Review 1.  MicroRNAs in the human pituitary.

Authors:  Milani Sivapragasam; Fabio Rotondo; Ricardo V Lloyd; Bernd W Scheithauer; Michael Cusimano; Luis V Syro; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

2.  MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.

Authors:  Giampaolo Trivellin; Henriett Butz; Juliette Delhove; Susana Igreja; Harvinder S Chahal; Vladimir Zivkovic; Tristan McKay; Attila Patócs; Ashley B Grossman; Márta Korbonits
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-17       Impact factor: 4.310

3.  MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.

Authors:  Stefano Caramuta; Suzanne Egyházi; Monica Rodolfo; Daniela Witten; Johan Hansson; Catharina Larsson; Weng-Onn Lui
Journal:  J Invest Dermatol       Date:  2010-04-01       Impact factor: 8.551

Review 4.  MicroRNAs and possible role in pituitary adenoma.

Authors:  Maria Chiara Zatelli; Ettore C degli Uberti
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

5.  Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells.

Authors:  Damian G Romero; Maria W Plonczynski; Cristian A Carvajal; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2008-01-24       Impact factor: 4.736

6.  Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.

Authors:  Enjiao Zhang; Shuang Liu; Zhongfei Xu; Shaohui Huang; Xuexin Tan; Changfu Sun; Li Lu
Journal:  Tumour Biol       Date:  2014-05-31

Review 7.  MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?

Authors:  P Mathijs Voorhoeve
Journal:  Biochim Biophys Acta       Date:  2009-09-10

8.  Pttg1 inhibits TGFβ signaling in breast cancer cells to promote their growth.

Authors:  Guofeng Zhang; Qicheng Zhao; Songlin Yu; Rui Lin; Xianghua Yi
Journal:  Tumour Biol       Date:  2014-09-17

Review 9.  MicroRNAs in Human Pituitary Adenomas.

Authors:  Xu-Hui Li; Elaine Lu Wang; Hai-Meng Zhou; Katsuhiko Yoshimoto; Zhi Rong Qian
Journal:  Int J Endocrinol       Date:  2014-12-08       Impact factor: 3.257

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205
View more
  9 in total

1.  Pituitary miRNAs target GHRHR splice variants to regulate GH synthesis by mediating different intracellular signalling pathways.

Authors:  Yunyun Cheng; Ting Chen; Jie Song; Zhaohui Teng; Chunli Wang; Siyao Wang; Guanhong Lu; Tianqi Feng; Qien Qi; Qianyun Xi; Songcai Liu; Linlin Hao; Yongliang Zhang
Journal:  RNA Biol       Date:  2020-06-19       Impact factor: 4.652

Review 2.  Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?

Authors:  Cheol Ryong Ku; Vladimir Melnikov; Zhaoyun Zhang; Eun Jig Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

3.  Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways.

Authors:  Tomasz M Grzywa; Klaudia Klicka; Beata Rak; Dawid Mehlich; Filip Garbicz; Grzegorz Zieliński; Maria Maksymowicz; Emir Sajjad; Paweł K Włodarski
Journal:  Endocrine       Date:  2019-06-04       Impact factor: 3.633

Review 4.  Genetic and Epigenetic Causes of Pituitary Adenomas.

Authors:  Mengqi Chang; Chengxian Yang; Xinjie Bao; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-26       Impact factor: 5.555

Review 5.  The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma.

Authors:  Soudeh Ghafouri-Fard; Atefe Abak; Bashdar Mahmud Hussen; Mohammad Taheri; Guive Sharifi
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

Review 6.  GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer.

Authors:  Cecilia Catellani; Gloria Ravegnini; Chiara Sartori; Sabrina Angelini; Maria E Street
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-16       Impact factor: 5.555

Review 7.  MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands.

Authors:  Daniel G Henriques; Elisa B Lamback; Romulo S Dezonne; Leandro Kasuki; Monica R Gadelha
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

Review 8.  Genetic and Epigenetic Pathogenesis of Acromegaly.

Authors:  Masaaki Yamamoto; Yutaka Takahashi
Journal:  Cancers (Basel)       Date:  2022-08-10       Impact factor: 6.575

Review 9.  Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms.

Authors:  Vinaya Srirangam Nadhamuni; Márta Korbonits
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.